[HTML][HTML] Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers, WC Reinhold, D Sonkin… - Clinical …, 2020 - Springer
Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
[HTML][HTML] Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers, WC Reinhold, D Sonkin… - Clinical …, 2020 - ncbi.nlm.nih.gov
Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
[HTML][HTML] Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers… - Clinical …, 2020 - clinicalepigeneticsjournal …
Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer. SCLC
progression and treatment resistance involve epigenetic processes. However, links between …
progression and treatment resistance involve epigenetic processes. However, links between …
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
J Krushkal, T Silvers, WC Reinhold, D Sonkin… - Clinical …, 2020 - go.gale.com
Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers, WC Reinhold… - Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
[引用][C] Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers, WC Reinhold… - Clinical Epigenetics …, 2020 - jglobal.jst.go.jp
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests
potential chemotherapy targets | Article Information | J-GLOBAL Art J-GLOBAL ID:202102269049686927 …
potential chemotherapy targets | Article Information | J-GLOBAL Art J-GLOBAL ID:202102269049686927 …
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers, WC Reinhold… - Clinical …, 2020 - search.proquest.com
Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
[PDF][PDF] Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
J Krushkal, T Silvers, WC Reinhold, D Sonkin, S Vural… - 2020 - academia.edu
Background: Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
J Krushkal, T Silvers, WC Reinhold, D Sonkin… - Clinical …, 2020 - europepmc.org
Background Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
J Krushkal, T Silvers, WC Reinhold… - Clinical …, 2020 - search.ebscohost.com
Background: Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer.
SCLC progression and treatment resistance involve epigenetic processes. However, links …
SCLC progression and treatment resistance involve epigenetic processes. However, links …